Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


Preferences help
enabled [disable] Abstract
Number of results
2017 | 17 | 71 | 299–305

Article title

A twin pregnancy with a hydatidiform mole and a coexisting live fetus: prenatal diagnosis, treatment, and follow-up

Content

Title variants

PL
Ciąża bliźniacza przebiegająca w postaci zaśniadu groniastego współwystępującego z żywym płodem: rozpoznanie, postępowanie oraz obserwacja po zakończeniu ciąży

Languages of publication

EN

Abstracts

EN
Twin molar pregnancy with a hydatidiform mole and a coexisting live fetus is a rare form of gestational trophoblastic disease associated with an increased risk of obstetric complications and poor perinatal outcome. Prenatal diagnosis is essential for couple counseling and follow-up in Tertiary Reference Centers. Magnetic resonance imaging is important for the diagnostic differentiation of placental mesenchymal dysplasia and exclusion of myometrial invasion. Here we present a case of twin molar pregnancy with a hydatidiform mole and a coexisting live fetus diagnosed at gestational week 14 using two-dimensional (2D) and three-dimensional (3D) ultrasound and magnetic resonance imaging. We also describe the obstetric management and postmolar follow-up.
PL
Zaśniad groniasty stanowi łagodną postać ciążowej choroby trofoblastycznej (gestational trophoblastic disease, GTD)(1). W Brazylii ciążowa choroba trofoblastyczna stwierdzana jest 5–10 razy częściej(2) niż w Stanach Zjednoczonych i Europie(3,4). Zaśniad groniasty powstaje w wyniku nieprawidłowego zapłodnienia komórki jajowej i może przybierać dwie formy: zaśniadu groniastego całkowitego lub zaśniadu groniastego częściowego(1). Z klinicznego punktu widzenia taka reprodukcja materiału genetycznego może prowadzić do rozwinięcia się ciążowej neoplazji trofoblastu, która bez wdrożenia właściwego leczenia może skutkować śmiercią kobiety(1–4). Artykuł w wersji polskojęzycznej jest dostępny na stronie http://jultrason.pl/index.php/wydawnictwa/volume-17-no-71

Discipline

Year

Volume

17

Issue

71

Pages

299–305

Physical description

Contributors

author
  • Rio de Janeiro Trophoblastic Disease Center, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
author
  • Rio de Janeiro Trophoblastic Disease Center, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
author
  • Department of Radiology, Clínica de Diagnóstico por Imagem, Rio de Janeiro, Brazil
  • Department of Obstetrics, Paulista School of Medicine – Federal University of São Paulo, São Paulo, Brazil
  • Rio de Janeiro Trophoblastic Disease Center, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
  • Rio de Janeiro Trophoblastic Disease Center, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
  • Department of Obstetrics, Paulista School of Medicine – Federal University of São Paulo, São Paulo, Brazil

References

  • 1. Lurain JR: Gestational trophoblastic disease I: Epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol 2010; 203: 531–539.
  • 2. Braga A, Uberti EM, Fajardo Mdo C, Viggiano M, Sun SY, Grillo BM et al.: Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers: results after 12 years since International FIGO 2000 Consensus. J Reprod Med 2014; 59: 241–247.
  • 3. Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C et al.: Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl. 6): vi39–vi50.
  • 4. Berkowitz RS, Goldstein DP: Current advances in the management of gestational trophoblastic disease. Gynecol Oncol 2013; 128: 3–5.
  • 5. Lin LH, Maestá I, Braga A, Sun SY, Fushida K, Francisco RPV et al.: Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review. Gynecol Oncol 2017; 145: 88–95.
  • 6. Bajaj SK, Misra R, Gupta R, Nisha B, Thukral BB: Complete hydatidiform mole with coexisting twin fetus: usefulness of MRI in management planning. J Obstet Gynaecol India 2014; 64: 9–13.
  • 7. Sun SY, Goldstein DP, Bernstein MR, Horowitz NS, Mattar R, Maestá I et al.: Maternal near miss according to World Health Organization classification among women with a hydatidiform mole: Experience at the New England Trophoblastic Disease Center, 1994–2013. J Reprod Med 2016; 61: 210–214.
  • 8. Suksai M, Suwanrath C, Kor-Anantakul O, Geater A, Hanprasertpong T, Atjimakul T et al.: Complete hydatidiform mole with co-existing fetus: predictors of live birth. Eur J Obstet Gynecol Reprod Biol 2017; 212: 1–8.
  • 9. Sebire NJ, Foskett M, Paradinas FJ, Fisher RA, Francis RJ, Short D et al.: Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin. Lancet 2002; 359: 2165–2166.
  • 10. Nodler JL, Kim KH, Alvarez RD: Abnormally low hCG in a complete hydatidiform molar pregnancy: the hook effect. Gynecol Oncol Case Rep 2011; 1: 6–7.
  • 11. Nigam A, Kumari A, Gupta N: Negative urine pregnancy test in a molar pregnancy: is it possible? BMJ Case Rep 2014; 2014.
  • 12. Braga A, Moraes V, Maestá I, Amim Júnior J, Rezende-Filho Jd, Elias K et al.: Changing trends in the clinical presentation and management of complete hydatidiform mole among Brazilian women. Int J Gynecol Cancer 2016; 26: 984–990.
  • 13. Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ: Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: Experience of more than 1000 cases from a regional referral center. Ultrasound Obstet Gynecol 2006; 27: 56–60.
  • 14. Starikov R, Goldman R, Dizon DS, Kostadinov S, Carr S: Placental mesenchymal dysplasia presenting as a twin gestation with complete molar pregnancy. Obstet Gynecol 2011; 118: 445–449.
  • 15. Marusik C, Frykholm C, Ericson K, Wikström J, Axelsson O: Diagnosis of placental mesenchymal dysplasia with magnetic resonance imaging. Ultrasound Obstet Gynecol 2017; 49: 410–412.
  • 16. Sheik S, Al-Riyami N, Mathew NR, Al-Sukaiti R, Qureshi A, Mathew M: Twin pregnancy with a complete hydatidiform mole and a coexisting live fetus: rare entity. Sultan Qaboos Univ Med J 2015; 15: 550–553.
  • 17. Himoto Y, Kido A, Minamiguchi S, Moribata Y, Okumura R, Mogami H et al.: Prenatal differential diagnosis of complete hydatidiform mole with a twin live fetus and placental mesenchymal dysplasia by magnetic resonance imaging. J Obstet Gynaecol Res 2014; 40: 1894–1900.
  • 18. Wu TC, Shen SH, Chang SP, Chang CY, Guo WY: Magnetic resonance experience of a twin pregnancy with a normal fetus and hydatidiform mole: a case report. J Comput Assist Tomogr 2005; 29: 415–417.
  • 19. Marcorelles P, Audrezet MP, Le Bris MJ, Laurent Y, Chabaud JJ, Ferec C et al.: Diagnosis and outcome of complete hydatidiform mole coexisting with a live twin fetus. Eur J Obstet Gynecol Reprod Biol 2005; 118: 21–27.
  • 20. Madi JM, Braga A, Paganella MP, Litvin IE, Da Ros Wendland EM: Accuracy of p57KIP2 compared with genotyping for the diagnosis of complete hydatidiform mole: Protocol for a systematic review and meta-analysis. Syst Rev 2016; 5: 169.
  • 21. Royal College of Obstetricians and Gynaecologists: The Management of Gestational Trophoblastic Disease. Green-Top Guideline No. 38. RCOG 2010. Available from: https://www.rcog.org.uk/globalassets/documents/ guidelines/gtg_38.pdf.
  • 22. Tidy JA, Gillespie AM, Bright N, Radstone CR, Coleman RE, Hancock BW: Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol 2000; 78: 309–312.
  • 23. Braga A, Maestá I, Short D, Savage P, Harvey R, Seckl MJ: Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review. BJOG 2016; 123: 1330–1135.
  • 24. Matsui H, Sekiya S, Hando T, Wake N, Tomoda Y: Hydatidiform mole coexistent with a twin live fetus: A national collaborative study in Japan. Hum Reprod 2000; 15: 608–611.
  • 25. Massardier J, Golfier F, Journet D, Frappart L, Zalaquett M, Schott AM et al.: Twin pregnancy with complete hydatidiform mole and coexistent fetus: obstetrical and oncological outcomes in a series of 14 cases. Eur J Obstet Gynecol Reprod Biol 2009; 143: 84–87.
  • 26. Niemann I, Sunde L, Petersen LK: Evaluation of the risk of persistent trophoblastic disease after twin pregnancy with diploid hydatidiform mole and coexisting normal fetus. Am J Obstet Gynecol 2007; 197: 45.e1–45.e5.
  • 27. Ngan HY, Bender H, Benedet JL, Jones H, Montruccoli GC, Pecorelli S et al.: Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet 2003; 83: 175–177.
  • 28. Kohorn EI: Worldwide survey of the results of treating gestational trophoblastic disease. J Reprod Med 2014; 59: 145–153.
  • 29. Dantas PR, Maestá I, Cortés-Charry R, Growdon WB, Braga A, Rudge MV et al.: Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study. J Reprod Med 2012; 57: 305–309.

Document Type

article

Publication order reference

Identifiers

YADDA identifier

bwmeta1.element.psjd-5ba2cb9b-d345-4464-8343-b1392970f8a0
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.